Exclusion Criteria:~* The subject has taken galantamine or memantine within 60 days prior to Screening Visit
1.~* The subject has received excluded concomitant medications.~* The subject has clinically significant
abnormal laboratory values at Screening Visit 1 as determined by the investigator.~* The subject has a history
of any significant neurologic disease other than Alzheimer's disease including Parkinson's disease,
multi-infarct or vascular dementia, Huntington's disease, normal pressure hydrocephalus, progressive
supranuclear palsy, multiple sclerosis, any seizures, mental retardation or a history of significant head
trauma followed by persistent neurologic deficits or known structural brain abnormalities.~* In the opinion of
the investigator, the subject has any clinically significant uncontrolled medical or psychiatric illness.
